Shire Plc is partnering with California-based Rani Therapeutics to develop a new way to administer a drug to treat hemophilia A.
The Philippines has ordered French drugmaker Sanofi to stop the sale, distribution and marketing of its Dengvaxia dengue vaccine in the country.
J&J’s Janssen Biotech entered into a collaboration deal with Idorsia to jointly develop and market aprocitentan for hypertension and any derivative compounds.
A Zika vaccine Sanofi SA dropped during September 2017 under political pressure over pricing produced strong responses in more than 90 percent of those taking part in an early-stage clinical trial, U.S. researchers reported.
Sanofi’s Toujeo met the primary study objective in the first large head-to-head clinical trial, called BRIGHT study, comparing Toujeo with insulin degludec.
Montana sued OxyContin maker Purdue Pharma LP, withdrawing from a multistate investigation by attorneys general into opioid manufacturers’ marketing practices and joining a growing list of states that have broken off to pursue individual lawsuits.
Consumers who search online for prices of common medical procedures may be disappointed by what they find, a U.S. study suggests.
Shares of Ultragenyx sharply climbed after the company announced positive results from its Phase III study of burosumab in adults with X-linked hypophosphatemia (XLH).
The Philippines ordered a probe on Monday into the immunization of more than 730,000 children with a vaccine for dengue that has been suspended following an announcement by the French drug company Sanofi that it could worsen the disease in some cases.